Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer

Table 2

Studies evaluating the performance of FDG PET for the detection of distant metastases and synchronous 2nd tumor in HNC.

Author year	Number of patients	Positive PET	True positive (distant mets + 2nd primary)	False positive	Notes
Ng et al. [34], 2009	111	16	13/16	3/16	CT/MR detect 4/16
Chua et al. [35], 2009	68	6	5/6	1/6	CT + BS detect 4/6
Liu et al. [36], 2007	300	61	50/61	11/61
Yen et al. [37], 2005	118	32	24/32	8/32
Goerres et al. [12], 2003	34	8	7/8	1/8	PET modified Treatment in 15%
Sigg et al. [38], 2003	58	8	7/8	1/8	PET modified Treatment in 5%
Schwartz et al. [39], 2003	33	7	7/7	0/7
Total	722	138	113/138	25/138